Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avinashnarayan Venkatanarayan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Molecular Cell|January 18, 2020
Partners in Crime: Clandestine Operations among RAS-RAF Accomplices in Promoting TumorigenesisAvinashnarayan Venkatanarayan, Shiva Malek
Developmental Biology|April 5, 2022
Hunchback prevents notch-induced apoptosis in the serotonergic lineage of Drosophila MelanogasterErnesto Pérez, Avinashnarayan Venkatanarayan, Martha J Lundell
Cell Cycle (Georgetown, Tex.)|December 15, 2015
Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73Avinashnarayan Venkatanarayan, Payal Raulji, William Norton, et al.
Developmental Biology|March 11, 2021
Zfh-2 facilitates Notch-induced apoptosis in the CNS and appendages of Drosophila melanogasterAnanya R Guntur, Avinashnarayan Venkatanarayan, Sindhura Gangula, et al.
Free Radical Biology & Medicine|June 18, 2013
Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stressColins O Eno, Guoping Zhao, Avinashnarayan Venkatanarayan, et al.
Biochemistry|September 24, 2020
Dimerization Induced by C-Terminal 14-3-3 Binding Is Sufficient for BRAF Kinase ActivationNicholas P D Liau, Avinashnarayan Venkatanarayan, John G Quinn, et al.
Elife|May 31, 2019
NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinomaGanapati V Hegde, Cecile de la Cruz, Jennifer M Giltnane, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
Nature|November 20, 2014
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivoAvinashnarayan Venkatanarayan, Payal Raulji, William Norton, et al.
Nature Communications|September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancerRadia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Molecular Cell|January 18, 2020
Partners in Crime: Clandestine Operations among RAS-RAF Accomplices in Promoting TumorigenesisAvinashnarayan Venkatanarayan, Shiva Malek
Developmental Biology|April 5, 2022
Hunchback prevents notch-induced apoptosis in the serotonergic lineage of Drosophila MelanogasterErnesto Pérez, Avinashnarayan Venkatanarayan, Martha J Lundell
Cell Cycle (Georgetown, Tex.)|December 15, 2015
Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73Avinashnarayan Venkatanarayan, Payal Raulji, William Norton, et al.
Developmental Biology|March 11, 2021
Zfh-2 facilitates Notch-induced apoptosis in the CNS and appendages of Drosophila melanogasterAnanya R Guntur, Avinashnarayan Venkatanarayan, Sindhura Gangula, et al.
Free Radical Biology & Medicine|June 18, 2013
Noxa couples lysosomal membrane permeabilization and apoptosis during oxidative stressColins O Eno, Guoping Zhao, Avinashnarayan Venkatanarayan, et al.
Biochemistry|September 24, 2020
Dimerization Induced by C-Terminal 14-3-3 Binding Is Sufficient for BRAF Kinase ActivationNicholas P D Liau, Avinashnarayan Venkatanarayan, John G Quinn, et al.
Elife|May 31, 2019
NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinomaGanapati V Hegde, Cecile de la Cruz, Jennifer M Giltnane, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
Nature|November 20, 2014
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivoAvinashnarayan Venkatanarayan, Payal Raulji, William Norton, et al.
Nature Communications|September 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancerRadia M Johnson, Xueping Qu, Chu-Fang Lin, et al.
Pageof 2